Filter News
Area of Research
- (-) Nuclear Science and Technology (6)
- Advanced Manufacturing (5)
- Biological Systems (2)
- Biology and Environment (58)
- Building Technologies (2)
- Clean Energy (83)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Functional Materials for Energy (1)
- Fusion and Fission (6)
- Fusion Energy (2)
- Isotopes (24)
- Materials (34)
- Materials for Computing (6)
- National Security (5)
- Neutron Science (7)
- Quantum information Science (1)
- Supercomputing (13)
News Type
News Topics
- (-) Bioenergy (1)
- (-) Isotopes (5)
- (-) Sustainable Energy (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Biomedical (2)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (8)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Space Exploration (5)
- Transformational Challenge Reactor (3)
Media Contacts
![An interactive visualization shows potential progression of BECCS to address carbon dioxide reduction goals. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-09/BECCSMap_0.png?h=9697e475&itok=garhzl6i)
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new analysis by ORNL scientists.
![A selfie from the Curiosity rover as it explores the surface of Mars. Like many spacecraft, Curiosity uses a radioisotope power system to help fuel its mission. Credit: NASA/JPL-Caltech/MSSS](/sites/default/files/styles/list_page_thumbnail/public/2020-09/Curiousity_1.jpg?h=86a9dded&itok=Jo0vD321)
Radioactive isotopes power some of NASA’s best-known spacecraft. But predicting how radiation emitted from these isotopes might affect nearby materials is tricky
![Pu-238 pellet drawing](/sites/default/files/styles/list_page_thumbnail/public/2020-07/Plutonium_Illustration_Blur.png?h=b6236d98&itok=wvSAbP64)
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
![Solid radium sulfate sits in the bottom of a flask during the recovery process. Credit: Oak Ridge National Laboratory, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-06/Ac227%202.jpg?h=479d286c&itok=AiNceGva)
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
![The electromagnetic isotope separator system operates by vaporizing an element such as ruthenium into the gas phase, converting the molecules into an ion beam, and then channeling the beam through magnets to separate out the different isotopes. The electromagnetic isotope separator system operates by vaporizing an element such as ruthenium into the gas phase, converting the molecules into an ion beam, and then channeling the beam through magnets to separate out the different isotopes.](/sites/default/files/styles/list_page_thumbnail/public/6_1_17%20Ru_NF3_530uA%5B2%5D.jpg?itok=3OLnNZqa)
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.